QSigth 420MD Clinical Mass Spectrometry

QSigth 420MD Clinical Mass Spectrometry

Equipment

Information

Liquid chromatography-tandem mass spectrometry (LC-MS) is a relatively new technology in the field of clinical diagnostics. Mass spectrometry provides unparalleled sensitivity and specificity for the analysis of metabolites, particularly in the detection of structurally similar small molecules such as vitamins, steroids, and hormones, where it offers significant advantages.Although LC-MS has been used for newborn screening globally for many years, its application in specialized diagnostics is subject to higher restrictions. Automated operation, user-friendly software, and pre-packaged reagent kits are crucial for the further promotion of LC-MS. With the maturation and commercialization of the technology, improvements in these aspects will enhance the usability and reliability of the equipment, facilitating broader clinical applications and making it an essential tool in clinical diagnostics.
Virtue DiagnosticsZ6.A33Founded in 2019, Virtue Diagnostics is an in vitro diagnostic provider committed to platform innovation in emerging markets. We have built a management team with decades of experience in the in vitro diagnostic industry and a global vision, coupled with robust R&D, operation and commercialization capabilities. We set up our industrialization bases in China, Brazil and Indonesia, and R&D centers in Singapore, China and Brazil. We are continuously expanding our global footprint through cooperative R&D, investment, mergers and acquisitions. Focusing on oncology and chronic diseases, Virtue Diagnostics utilizes innovative technology platforms such as clinical mass spectrometry, multiplex immunohistochemistry and molecular diagnostics to expand the China market. Through local capabilities built in emerging countries, Virtue Diagnostics is providing completed diagnostics menu cross biochemistry, chemiluminescence and molecular technologies.

Join the event!